52

Shukra Pharmaceuticals LtdBOM 524632 Stock Report

Last reporting period 30 Sep, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XBOM - Bombay Stock Exchange

524632.BO Stock Analysis

52

Uncovered

Shukra Pharmaceuticals Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

0.56 %

Shares outstanding

43.79 B

Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. The company is headquartered in Ahmedabad, Gujarat. The firm operates in two sectors: pharmaceutical and laboratory. The firm's manufacturing plant is situated in Rakanpur, Gandhinagar. The firm's product portfolio includes antibiotics (penicillin), anti-biotics (cephalosporin), anti-biotics, macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, analgesic (NASID), muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic. The firm is engaged in manufacturing general formulations, such as tablets, capsules and small volume parenteral.

View Section: Eyestock Rating